Loading…
Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
OBJECTIVE: Comprehensive analysis of the 9p21 locus including the CDKN2A, ARF, and CDKN2B genes in 53 individuals from melanoma index cases considered to be at heightened risk of melanoma. METHODS: and Results: Using a combination of DNA sequencing, gene copy number by real time quantitative PCR, li...
Saved in:
Published in: | Journal of medical genetics 2006-01, Vol.43 (1), p.39-47 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 47 |
container_issue | 1 |
container_start_page | 39 |
container_title | Journal of medical genetics |
container_volume | 43 |
creator | Laud, K Marian, C Avril, M F Barrois, M Chompret, A Goldstein, A M Tucker, M A Clark, P A Peters, G Chaudru, V Demenais, F Spatz, A Smith, M W Lenoir, G M Bressac-de Paillerets, B |
description | OBJECTIVE: Comprehensive analysis of the 9p21 locus including the CDKN2A, ARF, and CDKN2B genes in 53 individuals from melanoma index cases considered to be at heightened risk of melanoma. METHODS: and Results: Using a combination of DNA sequencing, gene copy number by real time quantitative PCR, linkage analysis, and transcript analysis in haploid somatic cell hybrids, we found no evidence for germline alteration in either coding or non-coding domains of CDKN2A and CDKN2B. However, we identified a p14 super(ARF) exon 1 beta missense germline mutation (G16D) in a melanoma-neural system tumour syndrome (CMM+NST) family and a 8474 bp germline deletion from 196 bp upstream of p14 super(ARF) exon 1 beta initiation codon to 11233 bp upstream of exon 1 alpha of p16 super(INK4A) in a family with five melanoma cases. For three out of 10 families with at least three melanoma cases, the disease gene was unlinked to the 9p21 region, while linkage analysis was not fully conclusive for seven families. CONCLUSIONS: These data reinforce the hypothesis that ARF is a melanoma susceptibility gene and suggest that germline deletions specifically affecting p14 super(ARF) may not be solely responsible for NST susceptibility. Predisposition to CMM+NST could either be due to complete disruption of the CDKN2A locus or be the result of more complex genetic inheritance. In addition, the absence of any genetic alteration in 50 melanoma prone families or patients suggests the presence of additional tumour suppressor genes possibly in the 9p21 region, and on other chromosomes. |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17466167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17466167</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_174661673</originalsourceid><addsrcrecordid>eNqNjbFOwzAQQC0EEqHwDzehZoiIHdeBMQQqUKUOFXtlkmtjSGzjSxD8DN-KEWVnOt3de3pHLOFSXWdKSHnMkjwXIhOLm-KUnRG95DkvSq4S9lW7wQfs0JJ5R9BW959kCNwO6rvVWlQw91wBTR7D_HG9klV65bk8HKrNMk2j1P7Ct7BHiwTGwqKAAXtt3aDj2uIHNJriq3Ex1GLAFkYHz7E4Qodm343RbCEYev1p_7nn7GSne8KLw5yxy-X9U_2Q-eDeJqRxOxhqsI80uom2vJRKcVUW_wa_AQDjW1I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17466167</pqid></control><display><type>article</type><title>Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma</title><source>PubMed Central(OpenAccess)</source><creator>Laud, K ; Marian, C ; Avril, M F ; Barrois, M ; Chompret, A ; Goldstein, A M ; Tucker, M A ; Clark, P A ; Peters, G ; Chaudru, V ; Demenais, F ; Spatz, A ; Smith, M W ; Lenoir, G M ; Bressac-de Paillerets, B</creator><creatorcontrib>Laud, K ; Marian, C ; Avril, M F ; Barrois, M ; Chompret, A ; Goldstein, A M ; Tucker, M A ; Clark, P A ; Peters, G ; Chaudru, V ; Demenais, F ; Spatz, A ; Smith, M W ; Lenoir, G M ; Bressac-de Paillerets, B</creatorcontrib><description>OBJECTIVE: Comprehensive analysis of the 9p21 locus including the CDKN2A, ARF, and CDKN2B genes in 53 individuals from melanoma index cases considered to be at heightened risk of melanoma. METHODS: and Results: Using a combination of DNA sequencing, gene copy number by real time quantitative PCR, linkage analysis, and transcript analysis in haploid somatic cell hybrids, we found no evidence for germline alteration in either coding or non-coding domains of CDKN2A and CDKN2B. However, we identified a p14 super(ARF) exon 1 beta missense germline mutation (G16D) in a melanoma-neural system tumour syndrome (CMM+NST) family and a 8474 bp germline deletion from 196 bp upstream of p14 super(ARF) exon 1 beta initiation codon to 11233 bp upstream of exon 1 alpha of p16 super(INK4A) in a family with five melanoma cases. For three out of 10 families with at least three melanoma cases, the disease gene was unlinked to the 9p21 region, while linkage analysis was not fully conclusive for seven families. CONCLUSIONS: These data reinforce the hypothesis that ARF is a melanoma susceptibility gene and suggest that germline deletions specifically affecting p14 super(ARF) may not be solely responsible for NST susceptibility. Predisposition to CMM+NST could either be due to complete disruption of the CDKN2A locus or be the result of more complex genetic inheritance. In addition, the absence of any genetic alteration in 50 melanoma prone families or patients suggests the presence of additional tumour suppressor genes possibly in the 9p21 region, and on other chromosomes.</description><identifier>ISSN: 0022-2593</identifier><identifier>EISSN: 1468-6244</identifier><language>eng</language><ispartof>Journal of medical genetics, 2006-01, Vol.43 (1), p.39-47</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Laud, K</creatorcontrib><creatorcontrib>Marian, C</creatorcontrib><creatorcontrib>Avril, M F</creatorcontrib><creatorcontrib>Barrois, M</creatorcontrib><creatorcontrib>Chompret, A</creatorcontrib><creatorcontrib>Goldstein, A M</creatorcontrib><creatorcontrib>Tucker, M A</creatorcontrib><creatorcontrib>Clark, P A</creatorcontrib><creatorcontrib>Peters, G</creatorcontrib><creatorcontrib>Chaudru, V</creatorcontrib><creatorcontrib>Demenais, F</creatorcontrib><creatorcontrib>Spatz, A</creatorcontrib><creatorcontrib>Smith, M W</creatorcontrib><creatorcontrib>Lenoir, G M</creatorcontrib><creatorcontrib>Bressac-de Paillerets, B</creatorcontrib><title>Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma</title><title>Journal of medical genetics</title><description>OBJECTIVE: Comprehensive analysis of the 9p21 locus including the CDKN2A, ARF, and CDKN2B genes in 53 individuals from melanoma index cases considered to be at heightened risk of melanoma. METHODS: and Results: Using a combination of DNA sequencing, gene copy number by real time quantitative PCR, linkage analysis, and transcript analysis in haploid somatic cell hybrids, we found no evidence for germline alteration in either coding or non-coding domains of CDKN2A and CDKN2B. However, we identified a p14 super(ARF) exon 1 beta missense germline mutation (G16D) in a melanoma-neural system tumour syndrome (CMM+NST) family and a 8474 bp germline deletion from 196 bp upstream of p14 super(ARF) exon 1 beta initiation codon to 11233 bp upstream of exon 1 alpha of p16 super(INK4A) in a family with five melanoma cases. For three out of 10 families with at least three melanoma cases, the disease gene was unlinked to the 9p21 region, while linkage analysis was not fully conclusive for seven families. CONCLUSIONS: These data reinforce the hypothesis that ARF is a melanoma susceptibility gene and suggest that germline deletions specifically affecting p14 super(ARF) may not be solely responsible for NST susceptibility. Predisposition to CMM+NST could either be due to complete disruption of the CDKN2A locus or be the result of more complex genetic inheritance. In addition, the absence of any genetic alteration in 50 melanoma prone families or patients suggests the presence of additional tumour suppressor genes possibly in the 9p21 region, and on other chromosomes.</description><issn>0022-2593</issn><issn>1468-6244</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjbFOwzAQQC0EEqHwDzehZoiIHdeBMQQqUKUOFXtlkmtjSGzjSxD8DN-KEWVnOt3de3pHLOFSXWdKSHnMkjwXIhOLm-KUnRG95DkvSq4S9lW7wQfs0JJ5R9BW959kCNwO6rvVWlQw91wBTR7D_HG9klV65bk8HKrNMk2j1P7Ct7BHiwTGwqKAAXtt3aDj2uIHNJriq3Ex1GLAFkYHz7E4Qodm343RbCEYev1p_7nn7GSne8KLw5yxy-X9U_2Q-eDeJqRxOxhqsI80uom2vJRKcVUW_wa_AQDjW1I</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Laud, K</creator><creator>Marian, C</creator><creator>Avril, M F</creator><creator>Barrois, M</creator><creator>Chompret, A</creator><creator>Goldstein, A M</creator><creator>Tucker, M A</creator><creator>Clark, P A</creator><creator>Peters, G</creator><creator>Chaudru, V</creator><creator>Demenais, F</creator><creator>Spatz, A</creator><creator>Smith, M W</creator><creator>Lenoir, G M</creator><creator>Bressac-de Paillerets, B</creator><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20060101</creationdate><title>Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma</title><author>Laud, K ; Marian, C ; Avril, M F ; Barrois, M ; Chompret, A ; Goldstein, A M ; Tucker, M A ; Clark, P A ; Peters, G ; Chaudru, V ; Demenais, F ; Spatz, A ; Smith, M W ; Lenoir, G M ; Bressac-de Paillerets, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_174661673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laud, K</creatorcontrib><creatorcontrib>Marian, C</creatorcontrib><creatorcontrib>Avril, M F</creatorcontrib><creatorcontrib>Barrois, M</creatorcontrib><creatorcontrib>Chompret, A</creatorcontrib><creatorcontrib>Goldstein, A M</creatorcontrib><creatorcontrib>Tucker, M A</creatorcontrib><creatorcontrib>Clark, P A</creatorcontrib><creatorcontrib>Peters, G</creatorcontrib><creatorcontrib>Chaudru, V</creatorcontrib><creatorcontrib>Demenais, F</creatorcontrib><creatorcontrib>Spatz, A</creatorcontrib><creatorcontrib>Smith, M W</creatorcontrib><creatorcontrib>Lenoir, G M</creatorcontrib><creatorcontrib>Bressac-de Paillerets, B</creatorcontrib><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of medical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laud, K</au><au>Marian, C</au><au>Avril, M F</au><au>Barrois, M</au><au>Chompret, A</au><au>Goldstein, A M</au><au>Tucker, M A</au><au>Clark, P A</au><au>Peters, G</au><au>Chaudru, V</au><au>Demenais, F</au><au>Spatz, A</au><au>Smith, M W</au><au>Lenoir, G M</au><au>Bressac-de Paillerets, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma</atitle><jtitle>Journal of medical genetics</jtitle><date>2006-01-01</date><risdate>2006</risdate><volume>43</volume><issue>1</issue><spage>39</spage><epage>47</epage><pages>39-47</pages><issn>0022-2593</issn><eissn>1468-6244</eissn><abstract>OBJECTIVE: Comprehensive analysis of the 9p21 locus including the CDKN2A, ARF, and CDKN2B genes in 53 individuals from melanoma index cases considered to be at heightened risk of melanoma. METHODS: and Results: Using a combination of DNA sequencing, gene copy number by real time quantitative PCR, linkage analysis, and transcript analysis in haploid somatic cell hybrids, we found no evidence for germline alteration in either coding or non-coding domains of CDKN2A and CDKN2B. However, we identified a p14 super(ARF) exon 1 beta missense germline mutation (G16D) in a melanoma-neural system tumour syndrome (CMM+NST) family and a 8474 bp germline deletion from 196 bp upstream of p14 super(ARF) exon 1 beta initiation codon to 11233 bp upstream of exon 1 alpha of p16 super(INK4A) in a family with five melanoma cases. For three out of 10 families with at least three melanoma cases, the disease gene was unlinked to the 9p21 region, while linkage analysis was not fully conclusive for seven families. CONCLUSIONS: These data reinforce the hypothesis that ARF is a melanoma susceptibility gene and suggest that germline deletions specifically affecting p14 super(ARF) may not be solely responsible for NST susceptibility. Predisposition to CMM+NST could either be due to complete disruption of the CDKN2A locus or be the result of more complex genetic inheritance. In addition, the absence of any genetic alteration in 50 melanoma prone families or patients suggests the presence of additional tumour suppressor genes possibly in the 9p21 region, and on other chromosomes.</abstract></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2593 |
ispartof | Journal of medical genetics, 2006-01, Vol.43 (1), p.39-47 |
issn | 0022-2593 1468-6244 |
language | eng |
recordid | cdi_proquest_miscellaneous_17466167 |
source | PubMed Central(OpenAccess) |
title | Comprehensive analysis of CDKN2A (p16 super(INK4A)/p14 super(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A34%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20analysis%20of%20CDKN2A%20(p16%20super(INK4A)/p14%20super(ARF))%20and%20CDKN2B%20genes%20in%2053%20melanoma%20index%20cases%20considered%20to%20be%20at%20heightened%20risk%20of%20melanoma&rft.jtitle=Journal%20of%20medical%20genetics&rft.au=Laud,%20K&rft.date=2006-01-01&rft.volume=43&rft.issue=1&rft.spage=39&rft.epage=47&rft.pages=39-47&rft.issn=0022-2593&rft.eissn=1468-6244&rft_id=info:doi/&rft_dat=%3Cproquest%3E17466167%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_174661673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17466167&rft_id=info:pmid/&rfr_iscdi=true |